Table of Contents
Ulcers
Volume 2014 (2014), Article ID 729754, 4 pages
http://dx.doi.org/10.1155/2014/729754
Research Article

Anti-Inflammatory and Gastroprotective Evaluation of Prodrugs of Piroxicam

R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur 425 405, India

Received 28 June 2014; Accepted 13 August 2014; Published 26 August 2014

Academic Editor: Gyula Mozsik

Copyright © 2014 Vivekkumar K. Redasani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Therapeutically potential prodrugs of piroxicam were synthesized by effective masking of enolic hydroxyl group through generation of ester congeners. The reaction facilitated using N,N′-dicyclohexylcarbodiimide coupled with acetic acid, benzoic acid, p-toluic acid, m-toluic acid, and cinnamic acid. Synthesized prodrugs were characterized for confirmation of the said structures. The modification of piroxicam showed better anti-inflammatory activity as evoked by all prodrugs. Interestingly, compound 3e, cinnamic acid ester prodrug, depicted 75 percent inhibition of rat paw edema as compared to 56 percent for parent piroxicam at 6 h of study. The present work proves the applicability not only with increased anti-inflammatory activity, but also with marked attenuation in ulcerogenicity. Novel prodrug 3e, cinnamic acid derivative, was found to be the least ulcerogenic having ulcer index of 0.67 as compared to parent drug piroxicam with 2.67.